Similar articles for PMID: 30099922

Year	Number of Results
1991	1
2002	2
2004	1
2005	1
2007	1
2008	3
2009	4
2010	6
2011	7
2012	5
2013	4
2014	2
2015	9
2016	11
2017	12
2018	12
2019	18
2020	9
2021	6
2022	2
2023	2
2024	0

1

Impact of Time to Start Systemic Therapy on the Outcomes of Patients with Metastatic Colorectal Cancer Treated with First Line FOLFOX Chemotherapy; a Patient-Level Pooled Analysis of Two Clinical Trials.

Oweira H, Giryes A, Mannhart M, Decker M, Abdel-Rahman O. Oweira H, et al. Expert Rev Gastroenterol Hepatol. 2018 Oct;12(10):1069-1074. doi: 10.1080/17474124.2018.1511426. Epub 2018 Aug 20. Expert Rev Gastroenterol Hepatol. 2018. PMID: 30099922

2

Impact of diabetes comorbidity on the efficacy and safety of FOLFOX first-line chemotherapy among patients with metastatic colorectal cancer: a pooled analysis of two phase-III studies.

Abdel-Rahman O. Abdel-Rahman O. Clin Transl Oncol. 2019 Apr;21(4):512-518. doi: 10.1007/s12094-018-1939-8. Epub 2018 Sep 4. Clin Transl Oncol. 2019. PMID: 30182209

3

Prognostic Value of Baseline ALBI Score Among Patients With Colorectal Liver Metastases: A Pooled Analysis of Two Randomized Trials.

Abdel-Rahman O. Abdel-Rahman O. Clin Colorectal Cancer. 2019 Mar;18(1):e61-e68. doi: 10.1016/j.clcc.2018.09.008. Epub 2018 Sep 27. Clin Colorectal Cancer. 2019. PMID: 30348618

4

Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy.

Wang Z, Liang L, Yu Y, Wang Y, Zhuang R, Chen Y, Cui Y, Zhou Y, Liu T. Wang Z, et al. Cell Physiol Biochem. 2016;39(3):1239-46. doi: 10.1159/000447829. Epub 2016 Sep 5. Cell Physiol Biochem. 2016. PMID: 27595400 Free article.

5

ECOG performance score 0 versus 1: impact on efficacy and safety of first-line 5-FU-based chemotherapy among patients with metastatic colorectal cancer included in five randomized trials.

Abdel-Rahman O. Abdel-Rahman O. Int J Colorectal Dis. 2019 Dec;34(12):2143-2150. doi: 10.1007/s00384-019-03430-y. Epub 2019 Nov 16. Int J Colorectal Dis. 2019. PMID: 31732876

6

Effectiveness of Combining Bevacizumab With First-Line Chemotherapy Regimens for Metastatic Colorectal Cancer in Real-World Practice.

Bang YH, Hong YS, Lee JS, Lee KW, Han HS, Kim SY, Kim JW, Kim HK, Kim JW, Eun CK, Kim TW, Kim JE. Bang YH, et al. Clin Colorectal Cancer. 2021 Jun;20(2):101-112.e6. doi: 10.1016/j.clcc.2020.10.001. Epub 2020 Oct 28. Clin Colorectal Cancer. 2021. PMID: 33223477

7

Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.

Hegewisch-Becker S, Graeven U, Lerchenmüller CA, Killing B, Depenbusch R, Steffens CC, Al-Batran SE, Lange T, Dietrich G, Stoehlmacher J, Tannapfel A, Reinacher-Schick A, Quidde J, Trarbach T, Hinke A, Schmoll HJ, Arnold D. Hegewisch-Becker S, et al. Lancet Oncol. 2015 Oct;16(13):1355-69. doi: 10.1016/S1470-2045(15)00042-X. Epub 2015 Sep 8. Lancet Oncol. 2015. PMID: 26361971 Clinical Trial.

8

Impact of Sex on Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer: Pooled Analysis of 5 Randomized Trials.

Abdel-Rahman O. Abdel-Rahman O. Clin Colorectal Cancer. 2019 Jun;18(2):110-115.e2. doi: 10.1016/j.clcc.2018.12.006. Epub 2018 Dec 28. Clin Colorectal Cancer. 2019. PMID: 30679026

9

Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).

Hoff PM, Hochhaus A, Pestalozzi BC, Tebbutt NC, Li J, Kim TW, Koynov KD, Kurteva G, Pintér T, Cheng Y, van Eyll B, Pike L, Fielding A, Robertson JD, Saunders MP. Hoff PM, et al. J Clin Oncol. 2012 Oct 10;30(29):3596-603. doi: 10.1200/JCO.2012.42.6031. Epub 2012 Sep 10. J Clin Oncol. 2012. PMID: 22965965 Clinical Trial.

10

Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies.

Del Rio M, Mollevi C, Bibeau F, Vie N, Selves J, Emile JF, Roger P, Gongora C, Robert J, Tubiana-Mathieu N, Ychou M, Martineau P. Del Rio M, et al. Eur J Cancer. 2017 May;76:68-75. doi: 10.1016/j.ejca.2017.02.003. Epub 2017 Mar 8. Eur J Cancer. 2017. PMID: 28284171

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

98 results

Results by year